The global high-intensity focused ultrasound therapy market is expected to reach US$ 417.98 Mn in 2018 and is predicted to grow at a CAGR of 7.1% during the forecast period 2019 – 2027, to reach US$ 755.46 Mn by 2027.
The market for high-intensity focused ultrasound therapy is expected to grow, owing to factors such as growing cancer prevalence across the globe, rising incidences of kidney stone and prostate diseases, rising preference for non-invasive procedures. In addition, growing hospital industry in developing nations are likely to have a positive impact on the growth of the market in the coming years.
Genetic testing helps evaluate the chance of developing cancer in a lifetime. The genetic testing is done by searching for specific mutations in genes, chromosomes, or proteins. An inherited gene mutation causes hereditary cancer. An inherited gene is the one which is passed from parent to child in a family. Various methods are used for hereditary cancer testing; it includes genetic counseling. The counseling provides a discussion regarding recommendations for preventive care and screening with the patient. They support groups and other information resources and provide emotional support to the person getting the results.
Therapeutic ultrasound segment held a largest market share of the High-Intensity Focused Ultrasound therapy market. This segment is also expected to dominate the market in 2027 because it increases the healing rates, tissue relaxation, and its heating, local blood flow, and scar tissue breakdown. Moreover, others segment is expected to grow at significant rate, in the forecast period 2019 to 2027 because lithotripsy, thrombolysis, immunomodulation, and among others medical procedures are increasing.
Global high-intensity focused ultrasound therapy market is segmented by modality, method, application, and end user. On the basis of modality, the market is segmented into Therapeutic Ultrasound, Hemostasis, Others. On the basis of method, the market is segmented into Non-Invasive and Minimal-Invasive. On the basis of Application, the market is segmented into Uterine Fibroids, Prostate Cancer, Others. Based on end user, the market is segmented into Hospitals, Research Centers, and Diagnostic Centers. In 2018, the imaging held the largest share in the market, by diagnosis type.
Some of the major primary and secondary sources included in the report are, Food and Drug Administration, World Health Organization (WHO), Centers for Medicare & Medicaid Services (CMS), Cancer Organisation Soutien (CDS), National Institute of Cancer Prevention and Research (NICPR), National Cancer Institute, Canadian Institutes of Health Research (CIHR), Spanish Society of Medical Oncology (SEOM), and others.
Reasons to Buy
The market for high-intensity focused ultrasound therapy is expected to grow, owing to factors such as growing cancer prevalence across the globe, rising incidences of kidney stone and prostate diseases, rising preference for non-invasive procedures. In addition, growing hospital industry in developing nations are likely to have a positive impact on the growth of the market in the coming years.
Genetic testing helps evaluate the chance of developing cancer in a lifetime. The genetic testing is done by searching for specific mutations in genes, chromosomes, or proteins. An inherited gene mutation causes hereditary cancer. An inherited gene is the one which is passed from parent to child in a family. Various methods are used for hereditary cancer testing; it includes genetic counseling. The counseling provides a discussion regarding recommendations for preventive care and screening with the patient. They support groups and other information resources and provide emotional support to the person getting the results.
Therapeutic ultrasound segment held a largest market share of the High-Intensity Focused Ultrasound therapy market. This segment is also expected to dominate the market in 2027 because it increases the healing rates, tissue relaxation, and its heating, local blood flow, and scar tissue breakdown. Moreover, others segment is expected to grow at significant rate, in the forecast period 2019 to 2027 because lithotripsy, thrombolysis, immunomodulation, and among others medical procedures are increasing.
Global high-intensity focused ultrasound therapy market is segmented by modality, method, application, and end user. On the basis of modality, the market is segmented into Therapeutic Ultrasound, Hemostasis, Others. On the basis of method, the market is segmented into Non-Invasive and Minimal-Invasive. On the basis of Application, the market is segmented into Uterine Fibroids, Prostate Cancer, Others. Based on end user, the market is segmented into Hospitals, Research Centers, and Diagnostic Centers. In 2018, the imaging held the largest share in the market, by diagnosis type.
Some of the major primary and secondary sources included in the report are, Food and Drug Administration, World Health Organization (WHO), Centers for Medicare & Medicaid Services (CMS), Cancer Organisation Soutien (CDS), National Institute of Cancer Prevention and Research (NICPR), National Cancer Institute, Canadian Institutes of Health Research (CIHR), Spanish Society of Medical Oncology (SEOM), and others.
Reasons to Buy
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the high-intensity focused ultrasound therapy market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in the global high-intensity focused ultrasound therapy market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.
Table of Contents
1. Introduction
3. Research Methodology
4. Global High-Intensity focused ultrasound therapy - Market Landscape
5. Global High-Intensity Focused Ultrasound Therapy Market - Key Industry Dynamics
6. High-Intensity Focused Ultrasound Therapy Market - Global Analysis
7. High-Intensity Focused Ultrasound Therapy Market Analysis And Forecasts To 2027 - Modality
8. High-Intensity Focused Ultrasound Therapy Market Analysis And Forecasts To 2027 - Method
9. High-Intensity Focused Ultrasound Therapy Market Analysis And Forecasts To 2027 - Application
10. High-Intensity Focused Ultrasound Therapy Market Analysis And Forecasts To 2027 - End User
11. High-Intensity Focused Ultrasound Therapy Market, Revenue and Forecast to 2027 - Geographic Analysis
12. Global High-Intensity Focused Ultrasound Therapy Market -Industry Landscape
13. Global High-Intensity Focused Ultrasound Therapy Market-Key Company Profiles
14. Appendix
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Image Guided Therapy
- EDAP
- Sonacare Medical and LLC
- Koninklijke Philips N.V.
- Chongqing Haifu Medical Technology Co., Ltd.
- Shanghai A & S Science Technology Development Co.,Ltd
- Mianyang Sonic Electronic
- Insightec Ltd.
- Alpinion Medical Systems Co., Ltd.
- FUS Instruments